|
Originally published In Press as doi:10.1074/jbc.M201939200 on May 10, 2002
J. Biol. Chem., Vol. 277, Issue 29, 26194-26199, July 19, 2002
Nitric Oxide Uptake by Erythrocytes Is Primarily Limited by
Extracellular Diffusion Not Membrane Resistance*
Xiaoping
Liu §,
Alexandre
Samouilov ,
Jack R.
Lancaster Jr.¶, and
Jay L.
Zweier
From the Molecular and Cellular Biophysics
Laboratories, Department of Medicine, Division of Cardiology and the
Electron Paramagnetic Resonance Center, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21224 and the
¶ Departments of Physiology and Medicine, Louisiana State
University Health Sciences Center, New Orleans, Louisiana 70112
Received for publication, February 26, 2002, and in revised form, May 1, 2002
 |
ABSTRACT |
The process of NO transfer into erythrocytes
(RBCs) is of critical biological importance because it regulates the
bioavailability and diffusional distance of endothelial-derived NO. It
has been reported that the rate of NO reaction with oxyhemoglobin (Hb) within RBCs is nearly three orders of magnitude slower than that by
equal amounts of free oxyhemoglobin. Consistent with early studies on
oxygen uptake by RBCs, the process of extracellular diffusion was
reported to explain this much lower NO uptake by RBC encapsulated Hb
(Liu, X., Miller, M. J., Joshi, M. S., Sadowska-Krowicka, H., Clark,
D. A., and Lancaster, J. R., Jr. (1998) J. Biol.
Chem. 273, 18709-18713). However, it was subsequently proposed
that the RBC membrane provides the main resistance to NO uptake rather than the process of extracellular diffusion (Vaughn, M. W., Huang, K. T., Kuo, L., and Liao, J. C. (2000) J. Biol.
Chem. 275, 2342-2348). This conclusion was based on competition
experiments that were assumed to be able to determine the rate constant
of NO uptake by RBCs without extracelluar diffusion limitation. To test
the validity of this hypothesis, we theoretically analyzed competition experiments. Here, we show that competition experiments do not eliminate the extracellular diffusion limitation. Simulation of the
competition data indicates that the main resistance to NO uptake by
RBCs is caused by extracellular diffusion in the unstirred layer
surrounding each RBC but not by the RBC membrane. This
extracellular diffusion resistance is responsible for preventing
interference of NO signaling in the endothelium without the need for
special NO uptake by intracellular hemoglobin or a unique membrane
resistance mechanism.
 |
INTRODUCTION |
Nitric oxide (nitrogen monoxide, NO) has been recognized as a
critical physiological mediator in the regulation of vascular tone (1).
It is generated in vascular endothelium by a specific arginine-dependent NO synthase, NOS3. Free diffusion has
been considered to be the main process that determines how NO travels from the site of its formation to target sites where it exerts its
critical physiological functions (2, 3).
In the vascular lumen NO can be scavenged by hemoglobin subunits
(Hb)1 within RBCs. The
reaction of NO with myoglobin and hemoglobin is rapid (bimolecular rate
constant for oxyMb is kMb = 3 × 107 M 1 s 1 and for
oxyHb is kHb = 6-9 × 107
M 1 s 1) (4, 5). It has been
reported that 10 µM cell-free Hb is enough to trap almost
all NO production generated from endothelial cells and abolish
NO-mediated vasodilation (6, 7), while blood contains about 8 mM Hb, which is much higher than the quantity of Hb
required to completely eliminate NO-mediated functional effects. The
rapid reaction between NO and oxyhemoglobin raises the question of how
NO can escape from the large quantity of Hb in the blood vessel lumen
to exert physiological effects in the blood vessel wall after it is
generated from endothelial cells (2, 8). This has led to recent efforts
to understand and theoretically model the reaction process between NO
and Hb (9-12).
It was observed that the rate of NO reaction with RBC-enclosed Hb is
nearly three orders of magnitude slower than the rate of NO reaction
with free Hb (9). Based on a diffusion-limited reaction model where the
limiting step for NO reaction with RBC-enclosed Hb is diffusion of NO
from the solution to the surface of RBCs, it was found that the
calculated rate constant for the reaction between NO and RBC Hb is very
close to that experimentally determined with direct electrochemical
measurements. Recently, these experimental results were verified in
competition experiments comparing the scavenging of NO by free Hb to
that of RBC-enclosed Hb (13); however, it was concluded that the RBC
membrane is the main resistance to NO transfer into RBCs. This was
based on the following competition Equation 1, which was derived under
the assumption that much of extracellular diffusion resistance is
eliminated in competition experiments because NO is uniformly generated
in extracellular solution, and a high hematocrit (>5%) was used in
the experiments (13, 14).
|
(Eq. 1)
|
[metHb]c is the metHb concentration in
the cell-free control, [metHb]ex is the
extracellular metHb concentration, [Hb]RBC is
defined as the RBC-enclosed Hb concentration in solution if all the
RBCs were lysed, [Hb]ex is extracellular Hb
concentration, and [Hb] is the
initial [Hb] . kRBC and kHb are rate
constants of the NO reaction with RBCs and free Hb, respectively.
[metHb]ex is measured experimentally and
then the ratio of
kRBC/kHb is determined
from Equation 1 using these experimental data. It was found that the
ratio of kRBC/kHb has a
large increase as hematocrit changes from 1.6 to 5%, and then the
ratio slightly increases as hematocrit changes from 5 to 16%. The
large increase of kRBC as hematocrit changes
from 1.6 to 5% was attributed to the diminution of extracellular
diffusion resistance, and therefore the value of
kRBC, measured in the high hematocrit region,
was considered to be caused only by RBC membrane resistance.
The controversy about the resistance of RBCs to NO transfer is
analogous to that relating to explanations for RBC oxygen uptake. More
than 70 years ago, it was discovered that RBC oxygen uptake was
considerably slower than that of an equivalent concentration of free Hb
(15). Early investigators suggested that oxygen uptake by RBCs is
limited mainly by the transport of oxygen across the RBC membrane and
intracellular diffusion of oxygen based on the assumption that
extracellular oxygen gradients are not present in rapid mixing devices
(16, 17). However, it is now accepted that effective diffusion layers
around RBCs still exist in rapid mixing devices (18, 19) and are mainly
responsible for the resistance of RBC oxygen transfer (18-23).
Since the assumption of competition experiments was not based on strict
theoretical analysis, one may ask the following two questions. 1)
Is NO concentration really uniformly distributed in solution in the
competition experiments? 2) Does the value of
kRBC at high hematocrit (from 5 to 16%) really
represent the rate constant of transmembrane diffusion? To answer the
two questions, we have theoretically analyzed competition experiments
in this study. NO concentration, NO flux at RBC membrane, the formation rate of extracellular metHb, and the ratio of
kRBC/kHb are calculated and shown at different membrane permeabilities (Pm)
and hematocrits (Hct). Our results show that NO concentration is not
uniform in solution in competition experiments. Computer simulation of
competition data indicates that RBC NO uptake is primarily limited by
the extracellular diffusion resistance rather than the RBC membrane resistance.
 |
MATERIALS AND METHODS |
Model Assumptions--
The disc shape of RBC is replaced with a
spherical shape for simplifying the theoretical analysis. The effective
radius of the spherical RBC, r0, is determined from the
surface area of the disc shape (14). In this model, the spherical RBC
is fixed at the center of a limited spherical volume or container with a radius r1. The radius of the container is defined by the
hematocrit as the ratio of the RBC volume to the container
volume,r / r . For the competition
experiments, the RBC is surrounded with Hb solution that fills the
space between the surface of the RBC and the inner wall of the
container (Fig. 1). After adding an NO
donor to the extracellular Hb solution, the donor uniformly distributes
in the whole extracellular solution. NO released from the donor either
reacts with Hb in the extracellular solution to form metHb or transfers
into the RBC. NO that enters into the RBC is immediately scavenged by
the concentrated intracellular Hb so that NO concentration inside the
RBC is maintained very close to zero. Since NO is slowly released from
the NO donor and extracellular Hb concentration is much greater than NO
concentration in competition experiments, the extracellular Hb can be
considered to be homogeneously distributed in the solution. With these
assumptions we have analytically derived expressions to predict
extracellular NO concentration, NO flux at the RBC membrane, the
formation rate of extracellular metHb, and the ratio of
kRBC/kHb.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 1.
Diagram illustrating the competition model of
the NO reaction with free and RBC Hb. A spherical container of
radius r1 is filled with free extracellular Hb solution,
and a Hb-containing RBC with radius r0 is fixed at the
center of the container. The radius r1 is determined by the
Hct from the equation Hct = (r0/r1)3.
|
|
Mathematical Analysis of Diffusion in Competition
Experiments--
Based on the above assumptions, the following
diffusion-reaction equation and boundary conditions (Equations 2-4)
are used to describe the competition experiment for any hematocrit
(from 0 to 100%),
|
(Eq. 2)
|
|
(Eq. 3)
|
|
(Eq. 4)
|
where DNO is the diffusion constant of NO in the
extracellular solution; Pm is membrane permeability;
k1, kHb are the rate constants of decomposition of the NO donor and the NO reaction with Hb,
respectively; [A], [NO], [NO]m are NO donor
concentration, NO concentration in solution, and NO concentration on
the outer surface of the RBC, respectively; [Hb]ex is extracellular Hb concentration; and
r0 and r1 are radii of the RBC and the
spherical container as shown in Fig. 1, respectively. In solution, the
change of NO concentration at any location between r = r0 and r = r1 can be caused by
NO diffusion, NO generation, and NO consumption at that location, which
is expressed by the first, second, and third terms in Equation 2. At
the boundary r = r0, the diffusion rate of
NO into the RBC surface should be equal to the rate of NO transfer
across the RBC membrane, so we have Equation 3. At the boundary
r = r1, there is no net NO flow into or out
from the container surface, so the gradient of NO concentration at
r = r1 should be equal to zero as expressed
in Equation 4.
Computer Simulations--
All simulated curves in this study
were calculated from the analytical expressions derived in the next
section on a pentium III personal computer with QBasic programs.
 |
RESULTS |
The Effect of Hematocrit on NO Concentration Distribution--
To
test if increasing hematocrit can change the NO concentration
distribution from inhomogeneous to homogeneous, we directly solved the
diffusion-reaction Equation 2 and their boundary conditions, Equations
3 and 4.
Assuming that [A] and [Hb]ex are uniform in
the solution during the competition experiment, the general solution for Equation 2 can be expressed as Equation 5,
|
(Eq. 5)
|
where
|
(Eq. 6)
|
and constants a and b can be determined by boundary conditions in
Equations 3 and 4. Equation 5 is true for
[Hb]ex > 0 or for
k1[A]/kHb[Hb]ex = constant as [Hb]ex approaches zero. In
competition experiments, we have [Hb]ex > 0.
The combination of Equation 5 with Equations 3 and 4 give us Equation 7,
|
(Eq. 7)
|
where [NO]b is the NO concentration in solution in
the absence of RBCs,
|
(Eq. 8)
|
|
(Eq. 9)
|
|
(Eq. 10a)
|
and
|
(Eq. 10b)
|
according to the definition of hematocrit, Hct = r /
r , we can replace r1 with Hct in Equation 7. NO concentration distribution
profiles around the RBC for different Pm and Hct values are
shown in Fig. 2, A and
B. In the simulations, we used
[Hb]ex = 10 µM, kHb = 89 µM 1
s 1 (20 °C) (5), DNO = 2600 µm2/s (25 °C) (24). Since the molar volume of NO is
close to the molar volume of oxygen, their diffusion constant would be
similar (25). The diffusion constant of oxygen in solution at 25 °C is 2420 µm2/s (26); therefore, it is reasonable to take
the value of DNO = 2600 µm2/s as the NO
diffusion constant at 25 °C. In competition experiments, it was
assumed that when hematocrit was smaller then 5%, the extracellular diffusion resistance becomes significant as hematocrit decreases, but
kRBC calculated from the competition equation
did not include any extracellular diffusion resistance as the
hematocrit was greater than 10% (13). The profiles of NO concentration
that were drawn according to the assumption for competition experiments
are shown in Fig. 2C. In this assumption, the NO
concentration distribution in the diffusion layer must have a large
change to eliminate the inhomogeneous NO concentration distribution as
hematocrit increases from 0.2 to 5%.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Graph of the relative NO concentration,
[NO]/[NO]b versus the distance from
the RBC membrane (r r0). Parameters used in
the calculation are kHb = 89 µm/s,
DNO = 2600 µm2/s, r0 = 3.39 µm,
[Hb]ex = 10 µM, intracellular Hb
concentration cRBC = 2200 µM, Pm = 0.9 m/s (A), and Pm = 1.8 × 10 3 m/s (B). Arrows designate the
location of inner surface of the container at each relative hematocrit.
In C, curves of NO concentration are drawn according to the
assumption for competition experiments for three different hematocrits:
Hct = 0.2% (solid line), Hct = 5%
(dots), and 10% (dash).
|
|
The Effect of Hematocrit on the Flux of NO Transfer into
RBCs--
In order to further test how hematocrit affects the
extracellular diffusion resistance, we derived the analytical
expression for the flux of NO transfer into RBCs and analyzed how the
flux varies with hematocrit. If the flux largely increases with
hematocrit or the extracellular diffusion resistance largely decreases
with hematocrit, then membrane resistance may become the limiting step to NO transfer into RBCs.
The flux of NO diffusion into the RBC is given by Equation 11,
|
(Eq. 11)
|
where
|
(Eq. 12)
|
In competition experiments, NO donor or NO is used as a probe to
measure the ratio of
kRBC/kHb. It is assumed
that the physical properties of the RBC membrane and solution diffusion
resistances are independent of [NO] or NO donor concentration [A].
In Equation 11, Fin is proportional to [A], so we use
Fn = 3Fin/k1[A]r0 to obtain
a [NO]-independent flux. Fn is proportional to
Fin but independent of NO donor concentration [A]. The
first derivative of Fn with respect to
r1 can be derived from Equation 11 and is shown in Equation 13.
|
(Eq. 13)
|
Since dFn/dr1 is always larger
than zero, Fn will increase as r1
increases and decrease as r1 decreases. Fn will
decrease as Hct increases because r1 is inversely
proportional to Hct1/3 (Fig. 3).
No matter whether the membrane permeability Pm is as high
as 0.9 m/s or as low as 0.0018 m/s, Fn always decreases
with the increase of Hct. Since Fn does not increase as
hematocrit changes from 0 to 5%, extracellular diffusion resistance
cannot be appreciably reduced by increasing the hematocrit.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Calculated initial fluxes of NO transfer into
RBCs. The initial fluxes of NO on the surface of the RBC
versus hematocrit as Pm = 0.9 m/s (a)
and Pm = 1.8 × 10 3 m/s (b).
Other parameters used in the calculations are
kHb = 89 µM 1 s 1, DNO = 2600 µm 2/s, r0 = 3.39 µm, cRBC = 22000 µM, and [Hb]ex = 10 µM.
|
|
Expressions for the Formation Rate of Extracellular metHb
Concentration and the Ratio of
kRBC/kHb--
It is easy to prove that
Equation 1 can be derived from the following two rate equations shown
in Equations 14a and 14b,
|
(Eq. 14a)
|
|
(Eq. 14b)
|
where [metHb]RBC is defined as the
RBC-enclosed metHb in solution if all the RBCs were lysed and [NO] is
the extracellular NO concentration. [Hb]RBC
can be calculated from hematocrit by Equation 15.
|
(Eq. 15)
|
Considering that [metHb]RBC is defined in
the whole space within the spherical container, we have Equation 16,
|
(Eq. 16)
|
where the surface area of the RBC S is
4 r and the volume of the
spherical container VT is
4 r /3. Considering that
[metHb]ex is defined in the extracellular solution, we can obtain the formation rate of metHb in extracellular solution in Equation 17.
|
(Eq. 17)
|
The time course of [metHb]ex can be
obtained from Equation 17 using numerical integration methods. We
compared [metHb]ex predicted from Equation 17
with the published experimental data in Fig.
4. The points in Fig. 4, A-C
were read from Fig. 2(a), Fig. 4(a), and Fig.
5(a) in Ref. 13, respectively. Solid curves were
calculated from Equation 17. Parameters used in the calculations are
chosen as DNO = 2600 µm2/s and Pm = 0.9 m/s. Since kHb = 89 µM 1 s 1 was measured at
20 °C (5), we have extrapolated this value with a temperature
coefficient of 1.4 per 10 °C that was used in estimating rate
constants for the reaction of NO or CO with deoxyHb (27). Thus we
obtained kHb = 105 µM 1 s 1 at 25 °C. The
extrapolated value of kHb was then used in
calculating the curves in Fig. 4. Other experimental parameters, such
as initial extracellular Hb concentration, initial NO donor
concentration, and hematocrit, were the same as those used in the
competition experiments of Vaughn et al. (13).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Simulations of [metHb]ex
versus time for different values of hematocrit,
initial extracellular Hb concentration, and initial NO donor
concentration. All curves of [metHb]ex
(solid line) were calculated from Equation 17 with
DNO = 2600 µm2 s 1,
kHb = 105 µM 1
s 1, Pm = 0.9 m/s, and r0 = 3.39 µm. Other experimental parameters such as hematocrit, initial
extracellular Hb concentration
[Hb] and initial NO donor
concentration are the same as those for each set of experimental data.
Experimental data in panel A (
[Hb] = 7.5 µM,
[A]0 = 10/(1-Hct) µM), shown as
closed circles (Hct = 0%) and open circles
(Hct = 7.8%), were read from Fig. 2. Experimental data in
panel B (Hct = 15.6%, [A]0 = 10/(1-Hct)
µM), represented by closed circles
([Hb] = 40 µM) and open circles (
[Hb] = 10 µM), were read from Fig. 4 of Ref. 13. Experimental data
in panel C (Hct = 15.6%,
[Hb] = 10 µM), shown as closed circles
([A]0 = 15/(1 Hct) µM), open
circles ([A]0 = 10/(1 Hct)
µM), and closed triangles ([A]0 = 5/(1 Hct) µM) were read from Fig. 5
(curve a) of Ref. 13.
|
|
The expression for the ratio
kRBC/kHb can be obtained
by a combination of Equations 14a, 14b, and 15 with Equations 16 and 17
as shown in Equation 18.
|
(Eq. 18)
|
In Equation 18, [Hb]ex decreases with
time in a competition experiment. If [Hb]ex at
time t is known, one can find the ratio of
kRBC/kHb from the
equation at time t. In Fig. 5,
we compared the predicted curves from Equation 18 with the experimental
data. These experimental data were read from Fig. 3b of
Vaughn et al. (13), and the two curves of
kRBC/kHb versus hematocrit were calculated from Equation 18 as
Pm = 0.9 m/s (a) and Pm = 4.15 × 10 4 m/s (b). In calculations, we chose
DNO = 2600 µm2/s, kHb = 105 µM 1 s 1, which were the
same as those used in Fig. 4. The competition experiments were
performed with 9 µM (Hct > 4%) or 2 µM (Hct < 4%) of initial extracellular Hb
concentration (13). During competition experiments,
[Hb]ex was slowly consumed by the reaction with NO. From Fig. 2a in Ref. 13 we know that the maximum
value of
ln([Hb] /[Hb]ex)
in a competition experiment is about 1.3, so
[Hb]ex at the end of a competition experiment
could be as low as 2.5 µM if
([Hb] = 9 µM or 0.5 µM if ([Hb] = 2 µM. Thus, the average [Hb]ex is
chosen as 5 µM in our calculations. Fig. 5 shows that the
experimental data are in good agreement with curve a, which was
calculated under the assumption of extracellular diffusion limitation
(Pm = 0.9 m/s). However, curve b calculated under the
assumption of membrane resistance limitation (Pm = 4.15 × 10 4 m/s) is very different from the
experimental data.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Plot of
kRBC/kHb
versus hematocrit. Experimental data
(closed circles) were read from Fig. 3 (curve b)
of Ref. 13. Curves (solid lines) were calculated from
Equation 18. Parameters used in the calculation are
kHb = 105 µM 1
s 1, r0 = 3.39 µm, DNO = 2600 µm2/s, [Hb]ex = 5 µM, Pm = 0.9 m/s (curve a) and
Pm = 4.15 × 10 4 m/s (curve
b).
|
|
 |
DISCUSSION |
Our model predicts that the NO concentration at the RBC surface,
[NO]m, is close to zero if Pm = 0.9 m/s, a
value reported by Subczynski et al. (28) for lipid bilayer
membrane. In this case, NO uptake by RBCs would be limited by
extracellular diffusion (Fig. 2A). At Hct = 0.2%, the
distance between the RBC surface to the inner wall of the container,
r1 r0, is about 23.5 µm. There is a layer with a big NO concentration gradient (r r 0 < 6 µm) near the RBC, and a region of uniform NO concentration outside
the concentration gradient layer between r r 0 = 6 µm and r r 0 = 23.5 µm. The radius of the
container r1 decreases with the increase of hematocrit. As
Hct = 5%, (r1 r 0) is reduced to 5.8 µm, and the region of uniform NO concentration disappears. However,
the inhomogeneous NO concentration distribution within the
concentration gradient layer almost remains unchanged. Thus, in
contrast to the assumption of the competition experiments, increasing
hematocrit from 0.2 to 5% does not make NO concentration distribution
more homogeneous; rather NO concentration distribution is more
inhomogeneous. Further increasing hematocrit from 5 to 10% has little
effect on the NO concentration gradient near the RBC surface. NO uptake
by the RBC is still limited by extracellular diffusion because
[NO]m is still close to zero compared with the NO
concentration at the inner surface of the container,
[NO]c. Fig. 2B shows the profile of NO
concentration as the RBC membrane is 500 times lower, or Pm = 1.8 × 10 3 m/s. Similar to Pm = 0.9 m/s, the NO concentration distribution in solution as Pm = 1.8 × 10 3 m/s is more inhomogeneous, not more
homogeneous, as hematocrit increases from 0.2 to 5%. At Hct = 10%, the big NO concentration gradient still exists between the RBC
surface and the inner wall of the container. Simply speaking, Fig. 2,
A and B show that changing hematocrit from 1.6 to
10% has little effect on extracellular diffusion resistance no matter
if Pm is high or low. However, the original assumption of
competition experiments (Fig. 2C), which predicts a complete
conversion of inhomogeneous NO concentration distribution into
homogeneous NO concentration distribution is in conflict with those
predicted by the diffusion-reaction equation (Fig. 2, A and
B). Therefore, there is no theoretical basis from which to
claim that kRBC determined around Hct = 10% does not include any extracellular diffusion resistance.
In fact, there is evidence in the literature for an external
diffusional limitation for other small nonelectrolytes, such as
O2 and CO (29, 18) across the erythrocyte membrane.
Vandegriff and Olson (30) demonstrated that the rate of
O2 uptake by erythrocytes is inversely proportional to the
size of RBC (using erythrocytes from various species as well as
liposome-entrapped hemoglobin), a result directly predicted by the
existence of an unstirred layer (9, 30) and not predicted on the basis
of an inherent diffusion barrier (9, 30). Since NO and O2
have similar size and solubility, the permeability of RBC membrane to
the two small neutral molecules should be similar. In a previous study,
we showed that NO uptake by RBCs at a low hematocrit is limited by
extracellular diffusion (9). Vaughn et al. (13) also
demonstrated that extracellular diffusion is the main resistance to NO
uptake by RBCs as Hct = 1.6% in competition experiments. The
above theoretical analysis (refer to Fig. 2A) shows that if
NO uptake by RBCs is limited by extracellular diffusion resistance at
low hematocrit, the extracellular diffusion resistance would have
little change by increasing hematocrit from 0.2 to 10%. Thus NO uptake
by RBCs in competition experiments of Vaughn et al. (13)
would still be limited by extracellular diffusion resistance.
Fig. 4 shows that if NO uptake by RBCs is limited by extracellular
diffusion, or Pm = 0.9 m/s, the calculated curves of
[metHb]ex at different sets of hematocrit,
[Hb]ex and NO donor concentration are in good
agreement with experimental data. As shown in Fig. 5, the
experimentally determined ratios of
kRBC/kHb, except the one
as Hct = 1.6%, are very close to curve a (Pm = 0.9 m/s), indicating that extracellular diffusion is the main resistance to
NO uptake by RBCs. The experimentally determined ratio of
kRBC/kHb as Hct = 1.6% largely deviates from curve a. This large deviation is caused by
a low initial [Hb]ex (2 µM) that
was used in the experiment as Hct = 1.6%, because this low
[Hb]ex can result in a low ratio of
kRBC/kHb and may cause a
larger relative error in an experimental measurement of
[metHb]ex. If we let Pm = 4.15 × 1 0 4 m/s, a very low membrane permeability
suggested by Vaughn et al. (14), the simulated curve (curve
b) is much lower than the reported ratios of
kRBC/kHb.
The analysis above shows that the rate of NO uptake by RBCs is
primarily limited by extracellular NO diffusion in the competition experiments. Mathematically, as long as a non-zero diffusion flux exists around a RBC, the diffusion flux can be always related to a
diffusion layer as shown in Equation 19,
|
(Eq. 19)
|
where D is the diffusion coefficient; cb and
cs are bulk concentration and surface concentration,
respectively; and is the thickness of the diffusion layer. Here,
the diffusion layer is an imaginary layer, which is used to convert the
concentration gradient dc/dr on the RBC membrane into a
simple fraction (cb cs)/ . Thus, the
thickness of the diffusion layer is always related to the concentration
gradient on a given surface. In a competition experiment, NO is
generated around each RBC, so the diffusion layer is a layer within the
unstirred layer around each RBC. In a blood vessel, the shape of the
diffusion layer is much different. The blood flow creates an RBC-free
layer near the vessel wall and increased concentration of RBCs near the
center of the vessel like a flowing RBC cylinder (7, 10, 11). The
endothelium-derived NO needs to diffuse across the RBC-free layer to
reach RBCs. In this case, the diffusion layer is a layer within the
RBC-free layer surrounding the surface of the flowing RBC cylinder. The diffusion layer can reduce NO uptake by RBCs and enhance the effective NO diffusion distance in the vessel wall (10).
Finally, we point out that numerous previous studies with erythrocytes
do not support the possibility that it possesses an inherent diffusion
barrier to small nonelectrolytes, certainly not of the magnitude
proposed by Vaughn et al. (13, 14). The red cell membrane is
40% lipid, which represents a substantial surface of rapid access of
NO for diffusion. The lipid bilayer is highly unlikely to possess such
a barrier property, since the passive permeability of the RBC to
nonelectrolytes is very similar to artificial lipid vesicles (and also
other cell types) (31), and the permeability characteristics of lipid
vesicles made from whole erythrocyte membrane lipids is quantitatively
the same as for synthetic lipids (32). Also, the rate of lateral
diffusion of NO in the red cell membrane is similar to
phosphatidylcholine vesicles (33). O2 diffusion through
thin films of erythrocytes is similar to that through equivalent
thicknesses of free hemoglobin, indicating that the membrane possesses
no barrier (34). The presence of the complex cytoskeletal network of
the erythrocyte and/or binding of hemoglobin to the cytoskeleton also
exerts no influence, since the passive permeability of intact red cells to mannitol and erythritol is the same as inside-out vesicles, which
lack this cytoskeleton (35). In addition, if the cytoskeletal network
serves as a physical barrier, in order to account for a retardation in
entry of a factor of 800 (36) this mechanism would require that such a
network would cover all but 1/800 = 0.125% of the total inner
surface area of the membrane. The spectrin component is an elongated
rod that forms a web with large spaces inbetween (37). As suggested by
Huang et al. (36), hemoglobin could bind to the membrane and
conceivably cover parts of the surface. However, with 106
hemoglobin molecules bound to band 3 per erythrocyte (38) and the size
of hemoglobin at 64 × 55 × 50 Å3 (39), it can
be calculated that the maximum surface area covered by the bound
hemoglobin will be 45.7 µm2, whereas the total
erythrocyte surface area is 135 µm2 (40). This would not
explain a slowing of transmembrane NO movement of nearly 1000-fold.
In conclusion, the process of NO transfer into RBCs is of critical
biological importance as it regulates the bioavailability and diffusion
distance of endothelial derived NO. Our analysis shows that with
increasing hematocrit, the distribution of NO concentration becomes
more inhomogeneous rather than more homogeneous. Competition
experiments did not eliminate extracellular diffusion resistance in
measuring the ratio of
kRBC/kHb under the
reported experimental conditions. The rate of NO uptake by RBCs in
competition experiments is primarily limited by extracellular diffusion
not membrane resistance. The extremely low membrane permeability
suggested by Vaughn et al. (14) is not only in conflict with
many previous experimental results about O2 and NO uptake
by RBCs, but also inconsistent with their results about the ratio of
kRBC/kHb calculated from
the competition equation.
 |
ACKNOWLEDGEMENT |
We thank Dr. John S. Olson for helpful discussions.
 |
FOOTNOTES |
*
This work was supported by an American Heart Association
Scientist Development Grant (to X. L.) and National Institutes of Health Grants HL38324, HL63744, and HL65608 (to J. L. Z.) and DK46935
(to J. R. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: The EPR Center, Johns
Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Rm.
LA-14, Baltimore, MD 21224. Tel.: 410-550-0339; E-mail: xpliu@mail.jhmi.edu.
Published, JBC Papers in Press, May 10, 2002, DOI 10.1074/jbc.M201939200
 |
ABBREVIATIONS |
The abbreviations used are:
Hb, hemoglobin;
RBC, red blood cell;
Hct, hematocrit;
Mb, myoglobin.
 |
REFERENCES |
| 1.
|
Vallance, P.,
Collier, J.,
and Moncada, S.
(1989)
Lancet
2,
997-1000[Medline]
[Order article via Infotrieve]
|
| 2.
|
Lancaster, J. R., Jr.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8137-8141[Abstract/Free Full Text]
|
| 3.
|
Wood, J.,
and Garthwaite, J.
(1994)
Neuropharmacology
33,
1235-1244[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Eich, R. F., Li, T.,
Lemon, D. D.,
Doherty, D. H.,
Curry, S. R.,
Aitken, J. F.,
Mathews, A. J.,
Johnson, K. A.,
Smith, R. D.,
Phillips, G. N., Jr.,
and Olson, J, S.
(1996)
Biochemistry
35,
6976-6983[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Herold, S.,
Exner, M.,
and Nauser, T.
(2001)
Biochemistry
40,
3385-3395[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Martin, W.,
Villani, G. M.,
Jothianandan, D.,
and Furchgott, R. F.
(1985)
J. Pharmacol. Exp. Ther.
232,
708-716[Abstract/Free Full Text]
|
| 7.
|
Liao, J. C.,
Hein, T. W.,
Vaughn, M. W.,
Huang, K. T.,
and Kuo, L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8757-8761[Abstract/Free Full Text]
|
| 8.
|
Lancaster, J. R., Jr.
(1997)
Nitric Oxide
1,
18-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Liu, X.,
Miller, M. J.,
Joshi, M. S.,
Sadowska-Krowicka, H.,
Clark, D. A.,
and Lancaster, J. R., Jr.
(1998)
J. Biol. Chem.
273,
18709-18713[Abstract/Free Full Text]
|
| 10.
|
Vaughn, M. W.,
Kuo, L.,
and Liao, J. C.
(1998)
Am. J. Physiol.
274,
H1705-H1714
|
| 11.
|
Butler, A. R.,
Megson, I. L.,
and Wright, P. G.
(1998)
Biochim. Biophys. Acta
1425,
168-176[Medline]
[Order article via Infotrieve]
|
| 12.
|
Gow, A. J.,
Luchsinger, B. P.,
Pawloski, J. R.,
Singel, D. J.,
and Stamler, J. S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9027-9032[Abstract/Free Full Text]
|
| 13.
|
Vaughn, M. W.,
Huang, K. T.,
Kuo, L.,
and Liao, J. C.
(2000)
J. Biol. Chem.
275,
2342-2348[Abstract/Free Full Text]
|
| 14.
|
Vaughn, M. W.,
Huang, K. T.,
Kuo, L.,
and Liao, J. C.
(2001)
Nitric Oxide
5,
18-31[CrossRef][Medline]
[Order article via Infotrieve].,
|
| 15.
|
Hartridge, H.,
and Roughton, F. J. W.
(1927)
J. Physiol.
62,
232-242.,
|
| 16.
|
Nicholson, P.,
and Roughton, F. J. W.
(1951)
Proc. R. Soc. B
138,
241-264[Medline]
[Order article via Infotrieve]
|
| 17.
|
Holland, R. A.
(1967)
Respir. Physiol.
3,
307-317[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Coin, J. T.,
and Olson, J. S.
(1979)
J. Biol. Chem.
254,
1178-1190[Abstract/Free Full Text]
|
| 19.
|
Rice, S. A.
(1980)
Biophys. J.
29,
65-77[Medline]
[Order article via Infotrieve]
|
| 20.
|
Kutchai, H.
(1975)
Respir. Physiol.
23,
121-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Shibuya, I.,
Niizeki, K.,
and Kagawa, T.
(1988)
Adv. Exp. Med. Biol.
222,
219-229[Medline]
[Order article via Infotrieve]
|
| 22.
|
Merchuk, J. C.,
Tzur, Z.,
and Lightfoot, E. N.
(1983)
Chem. Eng. Sci.
38,
1315-1321[CrossRef]
|
| 23.
|
Vandegriff, K. D.,
and Olson, J. S
(1984)
Biophys. J.
45,
825-835[Medline]
[Order article via Infotrieve]
|
| 24.
|
Lide, D. R.
(1990-1991)
Handbook of chemistry and physics
, 71st Ed.
, pp. 6-151, CRC Press, Boca Raton, FL
|
| 25.
|
Wilke, C. R.,
and Chang, P.
(1955)
AIChE J.
1,
264-270[CrossRef]
|
| 26.
|
Lide, D. R.
(1999-2000)
Handbook of chemistry and physics
, 80th Ed.
, pp. 6-190, CRC Press, Boca Raton, FL
|
| 27.
|
Cassoly, R.,
and Gibson, Q.
(1975)
J. Mol. Biol.
91,
301-313[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Subczynski, W. K.,
Lomnicka, M.,
and Hyde, J. S.
(1996)
Free Radic. Res.
24,
343-349[Medline]
[Order article via Infotrieve]
|
| 29.
|
Huxley, V. H.,
and Kutchai, H.
(1981)
J. Physiol.
316,
75-83[Abstract/Free Full Text]
|
| 30.
|
Vandegriff, K. D.,
and Olson, J. S.
(1984)
J. Biol. Chem.
259,
12619-12627[Abstract/Free Full Text]
|
| 31.
|
Weiss, T. F.
(1996)
Cellular Biophysics
, Vol. I
, p. 149, MIT Press, Cambridge, MA
|
| 32.
|
Carruthers, A.,
and Melchior, D. L.
(1983)
Biochemistry
22,
5797-5807[CrossRef]
|
| 33.
|
Denicola, A.,
Souza, J. M.,
Radi, R.,
and Lissi, E.
(1996)
Arch. Biochem. Biophys.
328,
208-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Kutchai, H.,
and Staub, N. C.
(1969)
J. Gen. Physiol.
53,
576-589[Abstract/Free Full Text]
|
| 35.
|
Klonk, S.,
and Deuticke, B.
(1992)
Biochim. Biophys. Acta
1106,
143-150[Medline]
[Order article via Infotrieve]
|
| 36.
|
Huang, K. T.,
Vaughn, M. W.,
Hyduke, D. R.,
Van Herle, H.,
Hein, T. W.,
Zhang, C.,
Kuo, L.,
and Liao, J. C.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
11771-11776[Abstract/Free Full Text]
|
| 37.
|
Ursitti, J. A.,
Pumplin, D. W.,
Wade, J. B.,
and Bloch, R. J.
(1991)
Cell Motil. Cytoskel.
19,
227-243[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Shaklai, N.,
Yguerabide, J.,
and Ranney, H. M.
(1977)
Biochemistry
16,
5593-5597[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Voet, D.,
and Voet, J. G.
(1995)
Biochemistry
, 2nd Ed.
, p. 224, John Wiley and Sons, New York
|
| 40.
|
Evans, E.,
and Fung, Y. C.
(1972)
Microvasc. Res.
4,
335-347[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. C. Minneci, K. J. Deans, S. Shiva, H. Zhi, S. M. Banks, S. Kern, C. Natanson, S. B. Solomon, and M. T. Gladwin
Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H743 - H754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhu, S. Li, Z. M. Marshall, and A. R. Whorton
A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin
Am J Physiol Cell Physiol,
April 1, 2008;
294(4):
C1012 - C1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sakai, A. Sato, K. Masuda, S. Takeoka, and E. Tsuchida
Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier
J. Biol. Chem.,
January 18, 2008;
283(3):
1508 - 1517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liu, Q. Yan, K. L. Baskerville, and J. L. Zweier
Estimation of Nitric Oxide Concentration in Blood for Different Rates of Generation: EVIDENCE THAT INTRAVASCULAR NITRIC OXIDE LEVELS ARE TOO LOW TO EXERT PHYSIOLOGICAL EFFECTS
J. Biol. Chem.,
March 23, 2007;
282(12):
8831 - 8836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang and A. Edwards
A model of nitric oxide tubulovascular cross talk in a renal outer medullary cross section
Am J Physiol Renal Physiol,
February 1, 2007;
292(2):
F711 - F722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. N. Hall and J. Garthwaite
Inactivation of nitric oxide by rat cerebellar slices
J. Physiol.,
December 1, 2006;
577(2):
549 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Kone
NO Break-Ins at Water Gate
Hypertension,
July 1, 2006;
48(1):
29 - 30.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Kim-Shapiro, A. N. Schechter, and M. T. Gladwin
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2006;
26(4):
697 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rebel, S. Cao, H. Kwansa, S. Dore, E. Bucci, and R. C. Koehler
Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H1027 - H1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kavdia and A. S. Popel
Venular endothelium-derived NO can affect paired arteriole: a computational model
Am J Physiol Heart Circ Physiol,
February 1, 2006;
290(2):
H716 - H723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Qin, H. Kwansa, E. Bucci, R. J. Roman, and R. C. Koehler
Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin
J Appl Physiol,
January 1, 2006;
100(1):
336 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Azarov, K. T. Huang, S. Basu, M. T. Gladwin, N. Hogg, and D. B. Kim-Shapiro
Nitric Oxide Scavenging by Red Blood Cells as a Function of Hematocrit and Oxygenation
J. Biol. Chem.,
November 25, 2005;
280(47):
39024 - 39032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sampei, J. A. Ulatowski, Y. Asano, H. Kwansa, E. Bucci, and R. C. Koehler
Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion
Am J Physiol Heart Circ Physiol,
September 1, 2005;
289(3):
H1191 - H1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Philippides, S. R. Ott, P. Husbands, T. A. Lovick, and M. O'Shea
Modeling Cooperative Volume Signaling in a Plexus of Nitric Oxide Synthase-Expressing Neurons
J. Neurosci.,
July 13, 2005;
25(28):
6520 - 6532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O. Lundberg and E. Weitzberg
NO Generation From Nitrite and Its Role in Vascular Control
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2005;
25(5):
915 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tsuchiya, Y. Kanematsu, M. Yoshizumi, H. Ohnishi, K. Kirima, Y. Izawa, M. Shikishima, T. Ishida, S. Kondo, S. Kagami, et al.
Nitrite is an alternative source of NO in vivo
Am J Physiol Heart Circ Physiol,
May 1, 2005;
288(5):
H2163 - H2170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Tsoukias, M. Kavdia, and A. S. Popel
A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation
Am J Physiol Heart Circ Physiol,
March 1, 2004;
286(3):
H1043 - H1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Raines, G.-L. Cao, S. Porsuphatana, P. Tsai, G. M. Rosen, and P. Shapiro
Nitric Oxide Inhibition of ERK1/2 Activity in Cells Expressing Neuronal Nitric-oxide Synthase
J. Biol. Chem.,
February 6, 2004;
279(6):
3933 - 3940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xu, M. Cho, N. Y. Spencer, N. Patel, Z. Huang, H. Shields, S. B. King, M. T. Gladwin, N. Hogg, and D. B. Kim-Shapiro
Measurements of nitric oxide on the heme iron and {beta}-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation
PNAS,
September 30, 2003;
100(20):
11303 - 11308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Crawford, C. R. White, and R. P. Patel
Vasoactivity of S-nitrosohemoglobin: role of oxygen, heme, and NO oxidation states
Blood,
June 1, 2003;
101(11):
4408 - 4415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Condorelli and S. C. George
Free nitric oxide diffusion in the bronchial microcirculation
Am J Physiol Heart Circ Physiol,
December 1, 2002;
283(6):
H2660 - H2670.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|